心脏移植术后重度原发性移植物功能障碍的预测因素与结局:美国队列分析
基于美国器官共享联合网络数据库回顾性分析2023年9月至2025年3月5097例成人心脏移植受者,6.6%发生重度原发性移植物功能障碍(PGD)。移植前ECMO、循环死亡后捐献心脏、供体酸血症及受者胸骨切开史为独立预测因素。重度PGD组3个月生存率低于对照组,其中持续性重度PGD预后更差。
要点
- 移植前ECMO、DCD供心、供体酸血症和受者胸骨切开史增加重度PGD风险
- 重度PGD患者3个月生存率74.4%,显著低于对照组的96.8%
- 持续性重度PGD(72小时仍需MCS)3个月生存率仅67.2%
核心结论
- 心脏移植术后重度PGD与早期高死亡率相关,供受者匹配时考虑危险因素可能降低其发生率。
研究设计与样本
- 回顾性队列研究,纳入美国器官共享联合网络数据库2023年9月至2025年3月5097例孤立成人心脏移植受者。
主要发现
- 重度PGD发生率为6.6%(338/5097)。
- 移植前ECMO(AOR 2.55,p<0.001)、循环死亡后捐献心脏(AOR 2.13,p<0.001)、供体获取前酸血症(AOR 2.01,p<0.001)和受者胸骨切开史(AOR 1.83,p<0.001)是重度PGD的预测因素。
- 重度PGD组3个月生存率低于对照组(74.4% vs 96.8%,p<0.001)。
- 重度PGD中36.7%(124例)为短暂性,其3个月生存率高于持续性重度PGD组(88.0% vs 67.2%,p<0.001)。
临床怎么用
- 供受者匹配时应评估移植前ECMO、DCD供心、供体酸血症及受者胸骨切开史等重度PGD危险因素。
- 对重度PGD患者需关注机械循环支持持续时间,持续性者预后更差。
局限性
- 回顾性数据库研究,可能存在未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aims to assess predictors and outcomes of severe primary graft dysfunction (PGD) in a contemporary United States cohort. METHODS: The United Network for Organ Sharing database was retrospectively reviewed for isolated adult heart transplant recipients (September 2023-March 2025). The population was stratified into severe PGD (left or biventricular dysfunction within 24 hours following transplantation that requires mechanical circulatory support [MCS]) and control cohorts (all other recipients). Predictors of severe PGD were identified using multivariable logistic regression. The severe PGD cohort was further classified into transient severe primary graft dysfunction (TPGD, MCS off by 72 hours) vs. persistent severe primary graft dysfunction (PPGD, remained on MCS at 72 hours). The Kaplan-Meier method was used to compare 3-month survival between groups. RESULTS: During the study interval, 5,097 heart transplant recipients were identified in the United States, with 6.6% (n = 338) developing severe PGD. Predictors for severe PGD included pretransplant extracorporeal membrane oxygenation (adjusted odds ratio [AOR]: 2.55, p < 0.001), hearts from donation after circulatory death (AOR: 2.13, p < 0.001), donor acidemia before procurement (AOR: 2.01, p < 0.001), and recipient history of sternotomy (AOR: 1.83, p < 0.001). The severe PGD group experienced lower 3-month survival than the control group (74.4% vs 96.8%, p < 0.001). Among severe PGD cases, 36.7% (n = 124) experienced TPGD and had higher 3 month survial than PPGD group (88.0% vs 67.2%, p < 0.001). CONCLUSIONS: Severe PGD following heart transplantation is associated with high early mortality. Consideration of risk factors in donor and recipient matching may mitigate the incidence of severe PGD.
引用
- Cho PD, Zappacosta H, Song J, et al. Predictors and outcomes of severe primary graft dysfunction in heart transplantation: United States cohort analysis. J Heart Lung Transplant. 2025. PMID: 40846114. doi:10.1016/j.healun.2025.07.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。